Form 8-K - Current report:
SEC Accession No. 0001654954-19-008360
Filing Date
2019-07-19
Accepted
2019-07-19 16:04:42
Documents
4
Period of Report
2019-06-30
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sbfm_8k.htm 8-K 22419
2 SHARE TRANSFER AGREEMENT sbfm_ex1014.htm EX-10.14 2527
3 IMAGE sbfm_ex1014000.jpg GRAPHIC 81147
4 IMAGE sbfm_ex1014001.jpg GRAPHIC 37201
  Complete submission text file 0001654954-19-008360.txt   189601
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52898 | Film No.: 19963513
SIC: 8731 Services-Commercial Physical & Biological Research